Download PDF

Hanover Is Initially Seeking a Minimum of $10 Million From Institutional Investors to Develop and Commercialize Its Endogenous Stem Cell Therapies Using TVEMF for The Treatment of Various Diseases; The Company Has Not Received Any Commitments to Date
LOS ANGELES, CA — (Marketwired) — 11/20/13 — Hanover Portfolio Acquisitions (OTCQB: HVPA), an intellectual property acquisition, development […]